Table 1.
Variable | HIV - recipient | HIV + recipient | p-value |
---|---|---|---|
(n=29,848) | (n=75) | ||
Male gender | 21,183 (71.0%) | 55 (73.3%) | 0.747 |
Donor age (median years, IQR) | 30 (22–40) | 33 (23–38) | 0.481 |
Donor BMI (median kg/m2, IQR) | 26.3 (23.2–30.2) | 25.2 (23.0–29.8) | 0.308 |
Donor ethnicity | 0.111 | ||
White | 19,171 (64.2%) | 44 (58.7%) | |
Black | 4,741 (15.9%) | 12 (16.0%) | |
Hispanic | 4,997 (16.7%) | 19 (25.3%) | |
Other | 939 (3.1%) | - | |
Donor history | |||
Cigarette use | 4,023 (13.5%) | 10 (13.3%) | 1.000 |
Cocaine use | 5,468 (18.3%) | 21 (28.0%) | 0.044 |
Alcohol abuse | 4,775 (16.0%) | 10 (13.3%) | 0.638 |
Diabetes | 1,008 (3.4%) | 3 (4.0%) | 1.000 |
LVEF | 60 (55–65) | 60 (59–65) | 0.514 |
Inotrope use at procurement | 13590 (45.5%) | 24 (32.0%) | 0.025 |
Donor cause of death | 0.012 | ||
Anoxia | 7,602 (25.5%) | 28 (37.3%) | |
Cerebrovascular/stroke | 5,787 (19.4%) | 10 (13.3%) | |
Head trauma | 15,633 (52.4%) | 35 (46.7%) | |
CNS tumor | 180 (0.6%) | 2 (2.7%) | |
Other | 645 (2.2%) | - | |
ABO blood type | 0.147 | ||
A | 10,732 (36.0%) | 28 (37.3%) | |
B | 3,301 (11.1%) | 11 (14.7%) | |
AB | 646 (2.2%) | 4 (5.3%) | |
O | 15,169 (50.8%) | 32 (42.7%) | |
IQR, interquartile range; LVEF, left ventricular ejection fraction; CNS, central nervous system |